261 related articles for article (PubMed ID: 20528468)
21. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
[TBL] [Abstract][Full Text] [Related]
22. Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques.
Evans CF; Davtyan H; Petrushina I; Hovakimyan A; Davtyan A; Hannaman D; Cribbs DH; Agadjanyan MG; Ghochikyan A
Alzheimers Dement; 2014 May; 10(3):284-95. PubMed ID: 23916838
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy for Alzheimer's disease: DNA- and protein-based epitope vaccines.
Davtyan H; Petrushina I; Ghochikyan A
Methods Mol Biol; 2014; 1143():259-81. PubMed ID: 24715293
[TBL] [Abstract][Full Text] [Related]
24. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
Lemere CA
Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
[TBL] [Abstract][Full Text] [Related]
25. Effects of epitopes combination and adjuvants on immune responses to anti-Alzheimer disease DNA vaccines in mice.
He Y; Sun SH; Chen RW; Guo YJ; He XW; Huang L; Chen ZH; Shi K; Zhu WJ
Alzheimer Dis Assoc Disord; 2005; 19(4):171-7. PubMed ID: 16327342
[TBL] [Abstract][Full Text] [Related]
26. The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates.
Davtyan H; Ghochikyan A; Petrushina I; Hovakimyan A; Davtyan A; Cribbs DH; Agadjanyan MG
Alzheimers Dement; 2014 May; 10(3):271-83. PubMed ID: 24560029
[TBL] [Abstract][Full Text] [Related]
27. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
[TBL] [Abstract][Full Text] [Related]
28. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
[TBL] [Abstract][Full Text] [Related]
29. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
[TBL] [Abstract][Full Text] [Related]
30. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
[TBL] [Abstract][Full Text] [Related]
31. MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice.
Liu B; Frost JL; Sun J; Fu H; Grimes S; Blackburn P; Lemere CA
J Neurosci; 2013 Apr; 33(16):7027-37. PubMed ID: 23595760
[TBL] [Abstract][Full Text] [Related]
32. Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis.
Illouz T; Nicola R; Ben-Shushan L; Madar R; Biragyn A; Okun E
Commun Biol; 2021 Mar; 4(1):329. PubMed ID: 33712740
[TBL] [Abstract][Full Text] [Related]
33. Novel Abeta immunogens: is shorter better?
Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
[TBL] [Abstract][Full Text] [Related]
34. Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.
Lin X; Bai G; Lin L; Wu H; Cai J; Ugen KE; Cao C
Hum Vaccin Immunother; 2014; 10(7):2024-31. PubMed ID: 25424812
[TBL] [Abstract][Full Text] [Related]
35. A Novel Aβ B-Cell Epitope Vaccine (rCV01) for Alzheimer's Disease Improved Synaptic and Cognitive Functions in 3 × Tg-AD Mice.
Yu YZ; Liu S; Wang HC; Shi D; Xu Q; Zhou XW; Sun ZW; Huang PT
J Neuroimmune Pharmacol; 2016 Dec; 11(4):657-668. PubMed ID: 27147259
[TBL] [Abstract][Full Text] [Related]
36. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.
Ishii-Katsuno R; Nakajima A; Katsuno T; Nojima J; Futai E; Sasagawa N; Yoshida T; Watanabe Y; Ishiura S
Biochem Biophys Res Commun; 2010 Sep; 399(4):593-9. PubMed ID: 20682291
[TBL] [Abstract][Full Text] [Related]
37. Active Immunotherapy with 12-mer Aβ1-42-like Assembly Vaccine Shows Efficacy in Aged 3×Tg-AD Mice.
Fang H; Zhou G; Li Q; Wang H; Pang X; Xu Q; Yu Y
Curr Mol Med; 2021; 21(1):45-55. PubMed ID: 32338218
[TBL] [Abstract][Full Text] [Related]
38. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
[TBL] [Abstract][Full Text] [Related]
39. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages.
Asuni AA; Boutajangout A; Scholtzova H; Knudsen E; Li YS; Quartermain D; Frangione B; Wisniewski T; Sigurdsson EM
Eur J Neurosci; 2006 Nov; 24(9):2530-42. PubMed ID: 17100841
[TBL] [Abstract][Full Text] [Related]
40. Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.
Qu BX; Lambracht-Washington D; Fu M; Eagar TN; Stüve O; Rosenberg RN
Vaccine; 2010 Jul; 28(32):5280-7. PubMed ID: 20562015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
